Neurology Alert (Vol. 34, No. 8) - April 1, 2015

Read the Disclosure Information Below, then click “Continue” to begin testing.

Release date: April 2015

Valid through: April 2018

Target Audience

This activity is intended for the neurologist.

Subjects

  • Is Pediatric-onset MS a Neurodegenerative Disorder?
  • Autologous Hematopoietic Stem Cell Transplant for Relapsing-Remitting MS
  • ‘The Butterfly Effect’ Explains Weather Triggering of Migraine
  • Update in Treating Neuropathic Pain
  • Restless Legs Syndrome and Post-polio Syndrome
  • Stroke Alert: Intracranial Clot Extraction Results in Better Outcomes than IV Thrombolysis Alone

Objectives

  • Discuss current scientific data regarding the diagnosis and treatment of neurological disease
  • Discuss the pathogenesis and treatment of pain
  • Describe the basic science of brain function
  • Discuss new information regarding new drugs for commonly diagnosed neurological conditions

Credit Available

Physicians

  • Maximum of 2.25 AMA PRA Category 1 Credit(s)

Sponsor

This activity is sponsored by AHC Media.

Accreditation Statement

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

 

Credit Designation

Physicians

AHC Media designates this enduring material for a maximum of 2.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Listing

Authors

Eric Mallack, MD, MBE, Fellow, Division of Pediatric Neurology, Weill Cornell Medical College.

Barry E. Kosofsky, MD, PhD, Chief, Division of Pediatric Neurology, Goldsmith Professor of Pediatrics, Neurology and Neuroscience, and Radiology, Weill Cornell Medical College

Jai S. Perumal, MD, Assistant Professor of Neurology, Weill Cornell Medical College

Dara Jamieson, MD, Assistant Professor of Clinical Neurology, Weill Cornell Medical College

Michael Rubin, MD, Professor of Clinical Neurology, Weill Cornell Medical College

Alexander Shtilbans, MD, PhD, Assistant Professor of Neurology, Weill Cornell Medical College

Matthew E. Fink, MD, Louis and Gertrude Feil Professor in Clinical Neurology, Chairman, Department of Neurology, Weill Cornell Medical College, Neurologist-in-Chief, New York Presbyterian Hospital

Editors

Medical Editor: Matthew E. Fink, MD, Louis and Gertrude Feil Professor in Clinical Neurology, Chairman, Department of Neurology, Weill Cornell Medical College, Neurologist-in-Chief, New York Presbyterian Hospital

AHC Media executive editor: Leslie G. Coplin

Managing editor: Leslie Hamlin

Financial Disclosure

AuthorsEric Mallack, MD, MBE, Barry E. Kosofsky, MD, PhD, Dara Jamieson, MD, Michael Rubin, MD, and Alexander Shtilbans, MD, PhD report no financial relationships relevant to this field of study.

Author Jai S. Perumal, MD, reports she is on the speakers bureau for Biogen Idec, Teva Pharmaceuticals, Genzyme Corp., and Acorda Therapeutics.

Neurology Alert's editor in chief, Matthew Fink, MD, is a retained consultant for Procter & Gamble. Peer reviewer M. Flint Beal, MD; executive editor Leslie Coplin; and managing editor Leslie Hamlin report no financial relationships relevant to this field of study.

Copyright 2015, AHC Media. All rights reserved.